Company / R&D Expense
VivoSim Labs, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$5.5M
FY2025
5-year range
$1.1M / $8.9M
FY2021-FY2025
Trend
-38.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $1M in FY2022 to $18M in FY2018.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -17.9%.
Improved from $3M to $5M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +70.8%
- 5-Year CAGR
- -17.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -17.9%, indicating a declining trend.
- In FY2025, r&d expense decreased 38.1% year-over-year.
- Peak r&d expense was recorded in FY2018.
- Lowest r&d expense in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.72 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.5M | -38.1% |
| FY2024 | $8.9M | +167.6% |
| FY2023 | $3.3M | +201.0% |
| FY2022 | $1.1M | -79.1% |
| FY2021 | $5.3M | -64.2% |
| FY2020 | $14.8M | -17.8% |
| FY2019 | $18.0M | -0.3% |
| FY2018 | $18.0M | +39.4% |
| FY2017 | $12.9M | +62.0% |
| FY2016 | $8.0M | +132.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026